nodes	percent_of_prediction	percent_of_DWPC	metapath
Midazolam—SLC22A1—Cladribine—multiple sclerosis	0.0974	0.168	CbGbCtD
Midazolam—CYP2E1—Fingolimod—multiple sclerosis	0.0916	0.157	CbGbCtD
Midazolam—CYP2E1—Mitoxantrone—multiple sclerosis	0.0431	0.074	CbGbCtD
Midazolam—ABCB1—Methylprednisolone—multiple sclerosis	0.0299	0.0513	CbGbCtD
Midazolam—CYP3A4—Fingolimod—multiple sclerosis	0.0278	0.0477	CbGbCtD
Midazolam—CYP3A7-CYP3A51P—Dexamethasone—multiple sclerosis	0.0231	0.0398	CbGbCtD
Midazolam—CYP3A7—Dexamethasone—multiple sclerosis	0.0231	0.0398	CbGbCtD
Midazolam—CYP2E1—Dexamethasone—multiple sclerosis	0.0223	0.0384	CbGbCtD
Midazolam—CYP2B6—Dexamethasone—multiple sclerosis	0.022	0.0379	CbGbCtD
Midazolam—ABCB1—Mitoxantrone—multiple sclerosis	0.0218	0.0374	CbGbCtD
Midazolam—ABCB1—Betamethasone—multiple sclerosis	0.0194	0.0334	CbGbCtD
Midazolam—ABCB1—Prednisolone—multiple sclerosis	0.0192	0.0329	CbGbCtD
Midazolam—ABCB1—Prednisone—multiple sclerosis	0.0181	0.0311	CbGbCtD
Midazolam—CYP3A4—Methylprednisolone—multiple sclerosis	0.0179	0.0308	CbGbCtD
Midazolam—CYP3A5—Dexamethasone—multiple sclerosis	0.0173	0.0298	CbGbCtD
Midazolam—CYP3A4—Triamcinolone—multiple sclerosis	0.0136	0.0233	CbGbCtD
Midazolam—CYP3A4—Mitoxantrone—multiple sclerosis	0.013	0.0224	CbGbCtD
Midazolam—CYP3A4—Betamethasone—multiple sclerosis	0.0116	0.02	CbGbCtD
Midazolam—CYP3A4—Prednisolone—multiple sclerosis	0.0115	0.0197	CbGbCtD
Midazolam—ABCB1—Dexamethasone—multiple sclerosis	0.0113	0.0194	CbGbCtD
Midazolam—CYP3A4—Prednisone—multiple sclerosis	0.0108	0.0186	CbGbCtD
Midazolam—ABCB1—Methotrexate—multiple sclerosis	0.00907	0.0156	CbGbCtD
Midazolam—GABRR3—peripheral nervous system—multiple sclerosis	0.00775	0.0583	CbGeAlD
Midazolam—CYP3A4—Dexamethasone—multiple sclerosis	0.00676	0.0116	CbGbCtD
Midazolam—GABRR2—peripheral nervous system—multiple sclerosis	0.00672	0.0506	CbGeAlD
Midazolam—GABRR1—peripheral nervous system—multiple sclerosis	0.00647	0.0487	CbGeAlD
Midazolam—GABRR3—nerve—multiple sclerosis	0.00604	0.0455	CbGeAlD
Midazolam—GABRQ—nerve—multiple sclerosis	0.00604	0.0455	CbGeAlD
Midazolam—GABRR2—nerve—multiple sclerosis	0.00524	0.0394	CbGeAlD
Midazolam—GABRR1—nerve—multiple sclerosis	0.00504	0.0379	CbGeAlD
Midazolam—GABRR3—retina—multiple sclerosis	0.0025	0.0188	CbGeAlD
Midazolam—GABRR2—retina—multiple sclerosis	0.00217	0.0163	CbGeAlD
Midazolam—GABRR1—retina—multiple sclerosis	0.00209	0.0157	CbGeAlD
Midazolam—GABRA6—brainstem—multiple sclerosis	0.0018	0.0135	CbGeAlD
Midazolam—CYP4B1—cerebellum—multiple sclerosis	0.00138	0.0104	CbGeAlD
Midazolam—GABRR3—nervous system—multiple sclerosis	0.00136	0.0102	CbGeAlD
Midazolam—GABRQ—nervous system—multiple sclerosis	0.00136	0.0102	CbGeAlD
Midazolam—GABRB2—brainstem—multiple sclerosis	0.00133	0.00997	CbGeAlD
Midazolam—GABRD—medulla oblongata—multiple sclerosis	0.00131	0.00987	CbGeAlD
Midazolam—GABRQ—central nervous system—multiple sclerosis	0.00131	0.00985	CbGeAlD
Midazolam—GABRG1—medulla oblongata—multiple sclerosis	0.00126	0.0095	CbGeAlD
Midazolam—GABRB1—medulla oblongata—multiple sclerosis	0.00122	0.00921	CbGeAlD
Midazolam—GABRA2—brainstem—multiple sclerosis	0.00121	0.00911	CbGeAlD
Midazolam—GABRD—midbrain—multiple sclerosis	0.0012	0.00902	CbGeAlD
Midazolam—GABRG3—nervous system—multiple sclerosis	0.00119	0.00896	CbGeAlD
Midazolam—GABRR2—nervous system—multiple sclerosis	0.00118	0.00887	CbGeAlD
Midazolam—GABRA1—brainstem—multiple sclerosis	0.00117	0.00881	CbGeAlD
Midazolam—GABRG1—midbrain—multiple sclerosis	0.00115	0.00868	CbGeAlD
Midazolam—GABRG3—central nervous system—multiple sclerosis	0.00115	0.00862	CbGeAlD
Midazolam—GABRR1—nervous system—multiple sclerosis	0.00113	0.00853	CbGeAlD
Midazolam—GABRG1—spinal cord—multiple sclerosis	0.00113	0.00847	CbGeAlD
Midazolam—GABRB1—midbrain—multiple sclerosis	0.00112	0.00842	CbGeAlD
Midazolam—CYP4B1—brain—multiple sclerosis	0.00112	0.00842	CbGeAlD
Midazolam—GABRR2—cerebellum—multiple sclerosis	0.00111	0.00834	CbGeAlD
Midazolam—GABRR1—central nervous system—multiple sclerosis	0.00109	0.00822	CbGeAlD
Midazolam—GABRB1—spinal cord—multiple sclerosis	0.00109	0.00822	CbGeAlD
Midazolam—GABRQ—brain—multiple sclerosis	0.00104	0.00782	CbGeAlD
Midazolam—GABRD—nervous system—multiple sclerosis	0.000985	0.00742	CbGeAlD
Midazolam—GABRD—central nervous system—multiple sclerosis	0.000949	0.00714	CbGeAlD
Midazolam—GABRG1—nervous system—multiple sclerosis	0.000949	0.00714	CbGeAlD
Midazolam—GABRA6—nervous system—multiple sclerosis	0.000943	0.0071	CbGeAlD
Midazolam—GABRD—cerebellum—multiple sclerosis	0.000927	0.00698	CbGeAlD
Midazolam—GABRB2—medulla oblongata—multiple sclerosis	0.000924	0.00695	CbGeAlD
Midazolam—GABRG2—medulla oblongata—multiple sclerosis	0.000924	0.00695	CbGeAlD
Midazolam—GABRB1—nervous system—multiple sclerosis	0.00092	0.00692	CbGeAlD
Midazolam—GABRA5—nervous system—multiple sclerosis	0.000915	0.00689	CbGeAlD
Midazolam—GABRG1—central nervous system—multiple sclerosis	0.000913	0.00687	CbGeAlD
Midazolam—GABRG3—brain—multiple sclerosis	0.00091	0.00685	CbGeAlD
Midazolam—GABRA6—central nervous system—multiple sclerosis	0.000908	0.00683	CbGeAlD
Midazolam—GABRG1—cerebellum—multiple sclerosis	0.000893	0.00672	CbGeAlD
Midazolam—GABRA6—cerebellum—multiple sclerosis	0.000888	0.00668	CbGeAlD
Midazolam—GABRB1—central nervous system—multiple sclerosis	0.000886	0.00667	CbGeAlD
Midazolam—GABRA5—central nervous system—multiple sclerosis	0.000881	0.00663	CbGeAlD
Midazolam—GABRR1—brain—multiple sclerosis	0.000867	0.00652	CbGeAlD
Midazolam—GABRB1—cerebellum—multiple sclerosis	0.000866	0.00651	CbGeAlD
Midazolam—GABRA3—nervous system—multiple sclerosis	0.000852	0.00641	CbGeAlD
Midazolam—GABRG2—midbrain—multiple sclerosis	0.000845	0.00636	CbGeAlD
Midazolam—GABRB2—midbrain—multiple sclerosis	0.000845	0.00636	CbGeAlD
Midazolam—GABRA4—nervous system—multiple sclerosis	0.00083	0.00625	CbGeAlD
Midazolam—GABRB2—spinal cord—multiple sclerosis	0.000824	0.0062	CbGeAlD
Midazolam—GABRG2—spinal cord—multiple sclerosis	0.000824	0.0062	CbGeAlD
Midazolam—GABRA3—central nervous system—multiple sclerosis	0.00082	0.00617	CbGeAlD
Midazolam—GABRA1—medulla oblongata—multiple sclerosis	0.000816	0.00614	CbGeAlD
Midazolam—GABRA4—central nervous system—multiple sclerosis	0.000799	0.00601	CbGeAlD
Midazolam—GABRA4—cerebellum—multiple sclerosis	0.000781	0.00588	CbGeAlD
Midazolam—GABRD—brain—multiple sclerosis	0.000753	0.00567	CbGeAlD
Midazolam—GABRA1—midbrain—multiple sclerosis	0.000746	0.00561	CbGeAlD
Midazolam—GABRA1—spinal cord—multiple sclerosis	0.000728	0.00548	CbGeAlD
Midazolam—GABRG1—brain—multiple sclerosis	0.000725	0.00546	CbGeAlD
Midazolam—GABRA6—brain—multiple sclerosis	0.000721	0.00543	CbGeAlD
Midazolam—GABRB3—medulla oblongata—multiple sclerosis	0.00071	0.00534	CbGeAlD
Midazolam—GABRB1—brain—multiple sclerosis	0.000703	0.00529	CbGeAlD
Midazolam—GABRA5—brain—multiple sclerosis	0.000699	0.00526	CbGeAlD
Midazolam—GABRG2—nervous system—multiple sclerosis	0.000694	0.00523	CbGeAlD
Midazolam—GABRB2—nervous system—multiple sclerosis	0.000694	0.00523	CbGeAlD
Midazolam—GABRG2—central nervous system—multiple sclerosis	0.000668	0.00503	CbGeAlD
Midazolam—GABRB2—central nervous system—multiple sclerosis	0.000668	0.00503	CbGeAlD
Midazolam—GABRB2—cerebellum—multiple sclerosis	0.000653	0.00492	CbGeAlD
Midazolam—GABRG2—cerebellum—multiple sclerosis	0.000653	0.00492	CbGeAlD
Midazolam—GABRA3—brain—multiple sclerosis	0.000651	0.0049	CbGeAlD
Midazolam—GABRB3—midbrain—multiple sclerosis	0.000649	0.00488	CbGeAlD
Midazolam—GABRA4—brain—multiple sclerosis	0.000634	0.00477	CbGeAlD
Midazolam—GABRA2—nervous system—multiple sclerosis	0.000634	0.00477	CbGeAlD
Midazolam—GABRB3—spinal cord—multiple sclerosis	0.000633	0.00476	CbGeAlD
Midazolam—GABRE—nervous system—multiple sclerosis	0.000629	0.00473	CbGeAlD
Midazolam—GABRA1—nervous system—multiple sclerosis	0.000613	0.00461	CbGeAlD
Midazolam—GABRA2—central nervous system—multiple sclerosis	0.000611	0.0046	CbGeAlD
Midazolam—GABRE—central nervous system—multiple sclerosis	0.000606	0.00456	CbGeAlD
Midazolam—SLC22A1—nervous system—multiple sclerosis	0.000599	0.00451	CbGeAlD
Midazolam—GABRA2—cerebellum—multiple sclerosis	0.000597	0.00449	CbGeAlD
Midazolam—GABRA1—central nervous system—multiple sclerosis	0.00059	0.00444	CbGeAlD
Midazolam—GABRA1—cerebellum—multiple sclerosis	0.000577	0.00434	CbGeAlD
Midazolam—SLC22A1—central nervous system—multiple sclerosis	0.000577	0.00434	CbGeAlD
Midazolam—GABRB3—nervous system—multiple sclerosis	0.000533	0.00401	CbGeAlD
Midazolam—GABRG2—brain—multiple sclerosis	0.000531	0.00399	CbGeAlD
Midazolam—GABRB2—brain—multiple sclerosis	0.000531	0.00399	CbGeAlD
Midazolam—GABRB3—central nervous system—multiple sclerosis	0.000513	0.00386	CbGeAlD
Midazolam—GABRB3—cerebellum—multiple sclerosis	0.000502	0.00378	CbGeAlD
Midazolam—GABRA2—brain—multiple sclerosis	0.000485	0.00365	CbGeAlD
Midazolam—GABRE—brain—multiple sclerosis	0.000481	0.00362	CbGeAlD
Midazolam—GABRA1—brain—multiple sclerosis	0.000469	0.00353	CbGeAlD
Midazolam—SLC22A1—brain—multiple sclerosis	0.000458	0.00345	CbGeAlD
Midazolam—CYP2E1—medulla oblongata—multiple sclerosis	0.000451	0.0034	CbGeAlD
Midazolam—GABRB3—brain—multiple sclerosis	0.000408	0.00307	CbGeAlD
Midazolam—CYP2E1—spinal cord—multiple sclerosis	0.000403	0.00303	CbGeAlD
Midazolam—CYP2B6—nervous system—multiple sclerosis	0.000361	0.00272	CbGeAlD
Midazolam—ABCB1—retina—multiple sclerosis	0.000356	0.00268	CbGeAlD
Midazolam—CYP2B6—central nervous system—multiple sclerosis	0.000348	0.00262	CbGeAlD
Midazolam—CYP2E1—nervous system—multiple sclerosis	0.000339	0.00255	CbGeAlD
Midazolam—CYP2E1—central nervous system—multiple sclerosis	0.000327	0.00246	CbGeAlD
Midazolam—CYP2E1—cerebellum—multiple sclerosis	0.000319	0.0024	CbGeAlD
Midazolam—Cough—Mitoxantrone—multiple sclerosis	0.000312	0.00149	CcSEcCtD
Midazolam—Gastrointestinal disorder—Azathioprine—multiple sclerosis	0.000312	0.00149	CcSEcCtD
Midazolam—Hallucination—Methylprednisolone—multiple sclerosis	0.000308	0.00147	CcSEcCtD
Midazolam—Neuropathy peripheral—Dexamethasone—multiple sclerosis	0.000307	0.00147	CcSEcCtD
Midazolam—Neuropathy peripheral—Betamethasone—multiple sclerosis	0.000307	0.00147	CcSEcCtD
Midazolam—Anaphylactoid reaction—Methotrexate—multiple sclerosis	0.000306	0.00146	CcSEcCtD
Midazolam—Connective tissue disorder—Methylprednisolone—multiple sclerosis	0.000304	0.00145	CcSEcCtD
Midazolam—Anxiety—Mitoxantrone—multiple sclerosis	0.000304	0.00145	CcSEcCtD
Midazolam—Lethargy—Methotrexate—multiple sclerosis	0.000302	0.00144	CcSEcCtD
Midazolam—Visual impairment—Methylprednisolone—multiple sclerosis	0.000298	0.00142	CcSEcCtD
Midazolam—Feeling abnormal—Azathioprine—multiple sclerosis	0.000298	0.00142	CcSEcCtD
Midazolam—Osteoarthritis—Methotrexate—multiple sclerosis	0.000296	0.00141	CcSEcCtD
Midazolam—Confusional state—Mitoxantrone—multiple sclerosis	0.000295	0.0014	CcSEcCtD
Midazolam—Dizziness—Cladribine—multiple sclerosis	0.000294	0.0014	CcSEcCtD
Midazolam—Erythema—Prednisolone—multiple sclerosis	0.000294	0.0014	CcSEcCtD
Midazolam—Anaphylactic shock—Mitoxantrone—multiple sclerosis	0.000292	0.00139	CcSEcCtD
Midazolam—Eye disorder—Methylprednisolone—multiple sclerosis	0.000289	0.00138	CcSEcCtD
Midazolam—Shock—Mitoxantrone—multiple sclerosis	0.000287	0.00137	CcSEcCtD
Midazolam—Cardiac disorder—Methylprednisolone—multiple sclerosis	0.000287	0.00137	CcSEcCtD
Midazolam—Bradycardia—Dexamethasone—multiple sclerosis	0.000287	0.00137	CcSEcCtD
Midazolam—Bradycardia—Betamethasone—multiple sclerosis	0.000287	0.00137	CcSEcCtD
Midazolam—Tachycardia—Mitoxantrone—multiple sclerosis	0.000285	0.00136	CcSEcCtD
Midazolam—Skin disorder—Mitoxantrone—multiple sclerosis	0.000284	0.00135	CcSEcCtD
Midazolam—Irritability—Methotrexate—multiple sclerosis	0.000283	0.00135	CcSEcCtD
Midazolam—Vomiting—Cladribine—multiple sclerosis	0.000283	0.00135	CcSEcCtD
Midazolam—Mood swings—Methotrexate—multiple sclerosis	0.000281	0.00134	CcSEcCtD
Midazolam—Rash—Cladribine—multiple sclerosis	0.00028	0.00134	CcSEcCtD
Midazolam—Hallucination—Betamethasone—multiple sclerosis	0.00028	0.00134	CcSEcCtD
Midazolam—Hallucination—Dexamethasone—multiple sclerosis	0.00028	0.00134	CcSEcCtD
Midazolam—Dermatitis—Cladribine—multiple sclerosis	0.00028	0.00134	CcSEcCtD
Midazolam—Immune system disorder—Methylprednisolone—multiple sclerosis	0.00028	0.00133	CcSEcCtD
Midazolam—Mediastinal disorder—Methylprednisolone—multiple sclerosis	0.000279	0.00133	CcSEcCtD
Midazolam—Ataxia—Methotrexate—multiple sclerosis	0.000278	0.00133	CcSEcCtD
Midazolam—Headache—Cladribine—multiple sclerosis	0.000278	0.00133	CcSEcCtD
Midazolam—Vision blurred—Prednisolone—multiple sclerosis	0.000277	0.00132	CcSEcCtD
Midazolam—CYP2B6—brain—multiple sclerosis	0.000276	0.00208	CbGeAlD
Midazolam—CYP3A4—nervous system—multiple sclerosis	0.000273	0.00205	CbGeAlD
Midazolam—Hypotension—Mitoxantrone—multiple sclerosis	0.000273	0.0013	CcSEcCtD
Midazolam—Depression—Prednisone—multiple sclerosis	0.000272	0.0013	CcSEcCtD
Midazolam—Visual impairment—Dexamethasone—multiple sclerosis	0.000271	0.00129	CcSEcCtD
Midazolam—Visual impairment—Betamethasone—multiple sclerosis	0.000271	0.00129	CcSEcCtD
Midazolam—Mental disorder—Methylprednisolone—multiple sclerosis	0.000271	0.00129	CcSEcCtD
Midazolam—Erythema—Triamcinolone—multiple sclerosis	0.00027	0.00129	CcSEcCtD
Midazolam—Erythema—Methylprednisolone—multiple sclerosis	0.000269	0.00129	CcSEcCtD
Midazolam—Neuropathy peripheral—Prednisone—multiple sclerosis	0.000268	0.00128	CcSEcCtD
Midazolam—Hypersensitivity—Azathioprine—multiple sclerosis	0.000266	0.00127	CcSEcCtD
Midazolam—Nausea—Cladribine—multiple sclerosis	0.000264	0.00126	CcSEcCtD
Midazolam—Vertigo—Prednisolone—multiple sclerosis	0.000264	0.00126	CcSEcCtD
Midazolam—Syncope—Prednisolone—multiple sclerosis	0.000263	0.00126	CcSEcCtD
Midazolam—Eye disorder—Dexamethasone—multiple sclerosis	0.000263	0.00125	CcSEcCtD
Midazolam—Eye disorder—Betamethasone—multiple sclerosis	0.000263	0.00125	CcSEcCtD
Midazolam—CYP3A4—central nervous system—multiple sclerosis	0.000263	0.00198	CbGeAlD
Midazolam—Paraesthesia—Mitoxantrone—multiple sclerosis	0.000262	0.00125	CcSEcCtD
Midazolam—Dyspnoea—Mitoxantrone—multiple sclerosis	0.00026	0.00124	CcSEcCtD
Midazolam—Somnolence—Mitoxantrone—multiple sclerosis	0.00026	0.00124	CcSEcCtD
Midazolam—CYP2E1—brain—multiple sclerosis	0.000259	0.00195	CbGeAlD
Midazolam—ABCB1—medulla oblongata—multiple sclerosis	0.000257	0.00194	CbGeAlD
Midazolam—Dyspepsia—Mitoxantrone—multiple sclerosis	0.000257	0.00123	CcSEcCtD
Midazolam—Fatigue—Mitoxantrone—multiple sclerosis	0.000252	0.0012	CcSEcCtD
Midazolam—Pain—Mitoxantrone—multiple sclerosis	0.00025	0.00119	CcSEcCtD
Midazolam—Constipation—Mitoxantrone—multiple sclerosis	0.00025	0.00119	CcSEcCtD
Midazolam—Bradycardia—Prednisone—multiple sclerosis	0.00025	0.00119	CcSEcCtD
Midazolam—Erythema—Dexamethasone—multiple sclerosis	0.000245	0.00117	CcSEcCtD
Midazolam—Erythema—Betamethasone—multiple sclerosis	0.000245	0.00117	CcSEcCtD
Midazolam—Hallucination—Prednisone—multiple sclerosis	0.000244	0.00116	CcSEcCtD
Midazolam—Vertigo—Triamcinolone—multiple sclerosis	0.000243	0.00116	CcSEcCtD
Midazolam—Syncope—Triamcinolone—multiple sclerosis	0.000242	0.00116	CcSEcCtD
Midazolam—Vertigo—Methylprednisolone—multiple sclerosis	0.000242	0.00115	CcSEcCtD
Midazolam—Syncope—Methylprednisolone—multiple sclerosis	0.000242	0.00115	CcSEcCtD
Midazolam—Connective tissue disorder—Prednisone—multiple sclerosis	0.000241	0.00115	CcSEcCtD
Midazolam—Feeling abnormal—Mitoxantrone—multiple sclerosis	0.000241	0.00115	CcSEcCtD
Midazolam—Anaphylactic shock—Prednisolone—multiple sclerosis	0.00024	0.00114	CcSEcCtD
Midazolam—Dizziness—Azathioprine—multiple sclerosis	0.000239	0.00114	CcSEcCtD
Midazolam—Shock—Prednisolone—multiple sclerosis	0.000236	0.00112	CcSEcCtD
Midazolam—Cough—Triamcinolone—multiple sclerosis	0.000236	0.00112	CcSEcCtD
Midazolam—ABCB1—midbrain—multiple sclerosis	0.000235	0.00177	CbGeAlD
Midazolam—Tachycardia—Prednisolone—multiple sclerosis	0.000234	0.00112	CcSEcCtD
Midazolam—Urticaria—Mitoxantrone—multiple sclerosis	0.000232	0.00111	CcSEcCtD
Midazolam—Vomiting—Azathioprine—multiple sclerosis	0.00023	0.0011	CcSEcCtD
Midazolam—ABCB1—spinal cord—multiple sclerosis	0.000229	0.00173	CbGeAlD
Midazolam—Eye disorder—Prednisone—multiple sclerosis	0.000229	0.00109	CcSEcCtD
Midazolam—Anxiety—Methylprednisolone—multiple sclerosis	0.000229	0.00109	CcSEcCtD
Midazolam—Drowsiness—Methotrexate—multiple sclerosis	0.000228	0.00109	CcSEcCtD
Midazolam—Rash—Azathioprine—multiple sclerosis	0.000228	0.00109	CcSEcCtD
Midazolam—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—multiple sclerosis	0.000228	0.00109	CcSEcCtD
Midazolam—Dermatitis—Azathioprine—multiple sclerosis	0.000228	0.00109	CcSEcCtD
Midazolam—Depression—Methotrexate—multiple sclerosis	0.000228	0.00109	CcSEcCtD
Midazolam—Headache—Azathioprine—multiple sclerosis	0.000226	0.00108	CcSEcCtD
Midazolam—Dry mouth—Triamcinolone—multiple sclerosis	0.000225	0.00107	CcSEcCtD
Midazolam—Confusional state—Methylprednisolone—multiple sclerosis	0.000222	0.00106	CcSEcCtD
Midazolam—Immune system disorder—Prednisone—multiple sclerosis	0.000221	0.00106	CcSEcCtD
Midazolam—Anaphylactic shock—Triamcinolone—multiple sclerosis	0.00022	0.00105	CcSEcCtD
Midazolam—Vertigo—Dexamethasone—multiple sclerosis	0.00022	0.00105	CcSEcCtD
Midazolam—Vertigo—Betamethasone—multiple sclerosis	0.00022	0.00105	CcSEcCtD
Midazolam—Anaphylactic shock—Methylprednisolone—multiple sclerosis	0.00022	0.00105	CcSEcCtD
Midazolam—Syncope—Betamethasone—multiple sclerosis	0.00022	0.00105	CcSEcCtD
Midazolam—Syncope—Dexamethasone—multiple sclerosis	0.00022	0.00105	CcSEcCtD
Midazolam—Shock—Triamcinolone—multiple sclerosis	0.000217	0.00103	CcSEcCtD
Midazolam—Shock—Methylprednisolone—multiple sclerosis	0.000216	0.00103	CcSEcCtD
Midazolam—Nervous system disorder—Methylprednisolone—multiple sclerosis	0.000216	0.00103	CcSEcCtD
Midazolam—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.000215	0.00103	CcSEcCtD
Midazolam—Paraesthesia—Prednisolone—multiple sclerosis	0.000215	0.00103	CcSEcCtD
Midazolam—Tachycardia—Triamcinolone—multiple sclerosis	0.000215	0.00103	CcSEcCtD
Midazolam—Mental disorder—Prednisone—multiple sclerosis	0.000215	0.00102	CcSEcCtD
Midazolam—Nausea—Azathioprine—multiple sclerosis	0.000215	0.00102	CcSEcCtD
Midazolam—Tachycardia—Methylprednisolone—multiple sclerosis	0.000215	0.00102	CcSEcCtD
Midazolam—Skin disorder—Methylprednisolone—multiple sclerosis	0.000214	0.00102	CcSEcCtD
Midazolam—Erythema—Prednisone—multiple sclerosis	0.000213	0.00102	CcSEcCtD
Midazolam—Asthenia—Mitoxantrone—multiple sclerosis	0.00021	0.001	CcSEcCtD
Midazolam—Anxiety—Betamethasone—multiple sclerosis	0.000208	0.000992	CcSEcCtD
Midazolam—Anxiety—Dexamethasone—multiple sclerosis	0.000208	0.000992	CcSEcCtD
Midazolam—Hypotension—Methylprednisolone—multiple sclerosis	0.000205	0.00098	CcSEcCtD
Midazolam—Pain—Prednisolone—multiple sclerosis	0.000205	0.000978	CcSEcCtD
Midazolam—Vision blurred—Prednisone—multiple sclerosis	0.000201	0.000959	CcSEcCtD
Midazolam—Anaphylactic shock—Dexamethasone—multiple sclerosis	0.0002	0.000954	CcSEcCtD
Midazolam—Anaphylactic shock—Betamethasone—multiple sclerosis	0.0002	0.000954	CcSEcCtD
Midazolam—Paraesthesia—Triamcinolone—multiple sclerosis	0.000198	0.000944	CcSEcCtD
Midazolam—Feeling abnormal—Prednisolone—multiple sclerosis	0.000197	0.000942	CcSEcCtD
Midazolam—Paraesthesia—Methylprednisolone—multiple sclerosis	0.000197	0.000942	CcSEcCtD
Midazolam—Visual impairment—Methotrexate—multiple sclerosis	0.000197	0.000942	CcSEcCtD
Midazolam—Shock—Betamethasone—multiple sclerosis	0.000197	0.000938	CcSEcCtD
Midazolam—Shock—Dexamethasone—multiple sclerosis	0.000197	0.000938	CcSEcCtD
Midazolam—Dyspnoea—Triamcinolone—multiple sclerosis	0.000196	0.000937	CcSEcCtD
Midazolam—Nervous system disorder—Dexamethasone—multiple sclerosis	0.000196	0.000935	CcSEcCtD
Midazolam—Nervous system disorder—Betamethasone—multiple sclerosis	0.000196	0.000935	CcSEcCtD
Midazolam—Agitation—Prednisone—multiple sclerosis	0.000196	0.000935	CcSEcCtD
Midazolam—Tachycardia—Betamethasone—multiple sclerosis	0.000195	0.000931	CcSEcCtD
Midazolam—Tachycardia—Dexamethasone—multiple sclerosis	0.000195	0.000931	CcSEcCtD
Midazolam—Dyspepsia—Triamcinolone—multiple sclerosis	0.000194	0.000925	CcSEcCtD
Midazolam—Dyspepsia—Methylprednisolone—multiple sclerosis	0.000194	0.000923	CcSEcCtD
Midazolam—ABCB1—nervous system—multiple sclerosis	0.000193	0.00145	CbGeAlD
Midazolam—Vertigo—Prednisone—multiple sclerosis	0.000192	0.000914	CcSEcCtD
Midazolam—Eye disorder—Methotrexate—multiple sclerosis	0.000191	0.000913	CcSEcCtD
Midazolam—Syncope—Prednisone—multiple sclerosis	0.000191	0.000913	CcSEcCtD
Midazolam—Urticaria—Prednisolone—multiple sclerosis	0.00019	0.000908	CcSEcCtD
Midazolam—Cardiac disorder—Methotrexate—multiple sclerosis	0.00019	0.000907	CcSEcCtD
Midazolam—Fatigue—Triamcinolone—multiple sclerosis	0.00019	0.000906	CcSEcCtD
Midazolam—Fatigue—Methylprednisolone—multiple sclerosis	0.00019	0.000904	CcSEcCtD
Midazolam—Pain—Triamcinolone—multiple sclerosis	0.000188	0.000899	CcSEcCtD
Midazolam—Hypotension—Dexamethasone—multiple sclerosis	0.000187	0.000891	CcSEcCtD
Midazolam—Hypotension—Betamethasone—multiple sclerosis	0.000187	0.000891	CcSEcCtD
Midazolam—ABCB1—central nervous system—multiple sclerosis	0.000186	0.0014	CbGeAlD
Midazolam—Vomiting—Mitoxantrone—multiple sclerosis	0.000186	0.000886	CcSEcCtD
Midazolam—Immune system disorder—Methotrexate—multiple sclerosis	0.000185	0.000883	CcSEcCtD
Midazolam—Mediastinal disorder—Methotrexate—multiple sclerosis	0.000185	0.000881	CcSEcCtD
Midazolam—Rash—Mitoxantrone—multiple sclerosis	0.000184	0.000879	CcSEcCtD
Midazolam—Dermatitis—Mitoxantrone—multiple sclerosis	0.000184	0.000878	CcSEcCtD
Midazolam—Chills—Methotrexate—multiple sclerosis	0.000184	0.000877	CcSEcCtD
Midazolam—Headache—Mitoxantrone—multiple sclerosis	0.000183	0.000873	CcSEcCtD
Midazolam—ABCB1—cerebellum—multiple sclerosis	0.000182	0.00137	CbGeAlD
Midazolam—Feeling abnormal—Triamcinolone—multiple sclerosis	0.000182	0.000866	CcSEcCtD
Midazolam—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.000181	0.000864	CcSEcCtD
Midazolam—Anxiety—Prednisone—multiple sclerosis	0.000181	0.000864	CcSEcCtD
Midazolam—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	0.00018	0.000861	CcSEcCtD
Midazolam—Paraesthesia—Betamethasone—multiple sclerosis	0.00018	0.000856	CcSEcCtD
Midazolam—Paraesthesia—Dexamethasone—multiple sclerosis	0.00018	0.000856	CcSEcCtD
Midazolam—Mental disorder—Methotrexate—multiple sclerosis	0.000179	0.000856	CcSEcCtD
Midazolam—Erythema—Methotrexate—multiple sclerosis	0.000178	0.000851	CcSEcCtD
Midazolam—Hypersensitivity—Prednisolone—multiple sclerosis	0.000177	0.000842	CcSEcCtD
Midazolam—Dyspepsia—Dexamethasone—multiple sclerosis	0.000176	0.00084	CcSEcCtD
Midazolam—Dyspepsia—Betamethasone—multiple sclerosis	0.000176	0.00084	CcSEcCtD
Midazolam—Urticaria—Triamcinolone—multiple sclerosis	0.000175	0.000835	CcSEcCtD
Midazolam—Urticaria—Methylprednisolone—multiple sclerosis	0.000175	0.000833	CcSEcCtD
Midazolam—Anaphylactic shock—Prednisone—multiple sclerosis	0.000174	0.000831	CcSEcCtD
Midazolam—Nausea—Mitoxantrone—multiple sclerosis	0.000174	0.000828	CcSEcCtD
Midazolam—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	0.000173	0.000823	CcSEcCtD
Midazolam—Gastrointestinal disorder—Betamethasone—multiple sclerosis	0.000173	0.000823	CcSEcCtD
Midazolam—Fatigue—Dexamethasone—multiple sclerosis	0.000172	0.000822	CcSEcCtD
Midazolam—Fatigue—Betamethasone—multiple sclerosis	0.000172	0.000822	CcSEcCtD
Midazolam—Shock—Prednisone—multiple sclerosis	0.000171	0.000817	CcSEcCtD
Midazolam—Pain—Betamethasone—multiple sclerosis	0.000171	0.000816	CcSEcCtD
Midazolam—Pain—Dexamethasone—multiple sclerosis	0.000171	0.000816	CcSEcCtD
Midazolam—Nervous system disorder—Prednisone—multiple sclerosis	0.000171	0.000815	CcSEcCtD
Midazolam—Tachycardia—Prednisone—multiple sclerosis	0.00017	0.000811	CcSEcCtD
Midazolam—Skin disorder—Prednisone—multiple sclerosis	0.000169	0.000807	CcSEcCtD
Midazolam—Vision blurred—Methotrexate—multiple sclerosis	0.000168	0.000802	CcSEcCtD
Midazolam—Feeling abnormal—Dexamethasone—multiple sclerosis	0.000165	0.000786	CcSEcCtD
Midazolam—Feeling abnormal—Betamethasone—multiple sclerosis	0.000165	0.000786	CcSEcCtD
Midazolam—Hypersensitivity—Triamcinolone—multiple sclerosis	0.000162	0.000774	CcSEcCtD
Midazolam—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.000162	0.000773	CcSEcCtD
Midazolam—Vertigo—Methotrexate—multiple sclerosis	0.00016	0.000764	CcSEcCtD
Midazolam—Urticaria—Dexamethasone—multiple sclerosis	0.000159	0.000758	CcSEcCtD
Midazolam—Urticaria—Betamethasone—multiple sclerosis	0.000159	0.000758	CcSEcCtD
Midazolam—Dizziness—Prednisolone—multiple sclerosis	0.000158	0.000756	CcSEcCtD
Midazolam—Asthenia—Triamcinolone—multiple sclerosis	0.000158	0.000754	CcSEcCtD
Midazolam—Asthenia—Methylprednisolone—multiple sclerosis	0.000158	0.000753	CcSEcCtD
Midazolam—Paraesthesia—Prednisone—multiple sclerosis	0.000156	0.000746	CcSEcCtD
Midazolam—Pruritus—Triamcinolone—multiple sclerosis	0.000156	0.000744	CcSEcCtD
Midazolam—Cough—Methotrexate—multiple sclerosis	0.000156	0.000742	CcSEcCtD
Midazolam—Pruritus—Methylprednisolone—multiple sclerosis	0.000156	0.000742	CcSEcCtD
Midazolam—Dyspepsia—Prednisone—multiple sclerosis	0.000153	0.000731	CcSEcCtD
Midazolam—Rash—Prednisolone—multiple sclerosis	0.000151	0.000721	CcSEcCtD
Midazolam—Dermatitis—Prednisolone—multiple sclerosis	0.000151	0.00072	CcSEcCtD
Midazolam—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	0.000151	0.000719	CcSEcCtD
Midazolam—Fatigue—Prednisone—multiple sclerosis	0.00015	0.000716	CcSEcCtD
Midazolam—Headache—Prednisolone—multiple sclerosis	0.00015	0.000716	CcSEcCtD
Midazolam—Constipation—Prednisone—multiple sclerosis	0.000149	0.00071	CcSEcCtD
Midazolam—ABCB1—brain—multiple sclerosis	0.000148	0.00111	CbGeAlD
Midazolam—Confusional state—Methotrexate—multiple sclerosis	0.000147	0.0007	CcSEcCtD
Midazolam—Dizziness—Triamcinolone—multiple sclerosis	0.000146	0.000695	CcSEcCtD
Midazolam—Anaphylactic shock—Methotrexate—multiple sclerosis	0.000146	0.000694	CcSEcCtD
Midazolam—Dizziness—Methylprednisolone—multiple sclerosis	0.000145	0.000694	CcSEcCtD
Midazolam—Feeling abnormal—Prednisone—multiple sclerosis	0.000144	0.000685	CcSEcCtD
Midazolam—Asthenia—Betamethasone—multiple sclerosis	0.000143	0.000684	CcSEcCtD
Midazolam—Asthenia—Dexamethasone—multiple sclerosis	0.000143	0.000684	CcSEcCtD
Midazolam—Nervous system disorder—Methotrexate—multiple sclerosis	0.000143	0.000681	CcSEcCtD
Midazolam—Nausea—Prednisolone—multiple sclerosis	0.000142	0.000679	CcSEcCtD
Midazolam—Pruritus—Betamethasone—multiple sclerosis	0.000141	0.000675	CcSEcCtD
Midazolam—Pruritus—Dexamethasone—multiple sclerosis	0.000141	0.000675	CcSEcCtD
Midazolam—Skin disorder—Methotrexate—multiple sclerosis	0.000141	0.000674	CcSEcCtD
Midazolam—Vomiting—Triamcinolone—multiple sclerosis	0.00014	0.000668	CcSEcCtD
Midazolam—Vomiting—Methylprednisolone—multiple sclerosis	0.00014	0.000667	CcSEcCtD
Midazolam—Rash—Triamcinolone—multiple sclerosis	0.000139	0.000663	CcSEcCtD
Midazolam—Dermatitis—Triamcinolone—multiple sclerosis	0.000139	0.000662	CcSEcCtD
Midazolam—Rash—Methylprednisolone—multiple sclerosis	0.000139	0.000661	CcSEcCtD
Midazolam—Dermatitis—Methylprednisolone—multiple sclerosis	0.000139	0.000661	CcSEcCtD
Midazolam—Urticaria—Prednisone—multiple sclerosis	0.000138	0.00066	CcSEcCtD
Midazolam—Headache—Triamcinolone—multiple sclerosis	0.000138	0.000659	CcSEcCtD
Midazolam—Headache—Methylprednisolone—multiple sclerosis	0.000138	0.000657	CcSEcCtD
Midazolam—Hypotension—Methotrexate—multiple sclerosis	0.000136	0.000649	CcSEcCtD
Midazolam—Dizziness—Betamethasone—multiple sclerosis	0.000132	0.000631	CcSEcCtD
Midazolam—Dizziness—Dexamethasone—multiple sclerosis	0.000132	0.000631	CcSEcCtD
Midazolam—Nausea—Triamcinolone—multiple sclerosis	0.000131	0.000624	CcSEcCtD
Midazolam—Paraesthesia—Methotrexate—multiple sclerosis	0.000131	0.000623	CcSEcCtD
Midazolam—Nausea—Methylprednisolone—multiple sclerosis	0.000131	0.000623	CcSEcCtD
Midazolam—Dyspnoea—Methotrexate—multiple sclerosis	0.00013	0.000619	CcSEcCtD
Midazolam—Somnolence—Methotrexate—multiple sclerosis	0.000129	0.000617	CcSEcCtD
Midazolam—Hypersensitivity—Prednisone—multiple sclerosis	0.000128	0.000612	CcSEcCtD
Midazolam—Dyspepsia—Methotrexate—multiple sclerosis	0.000128	0.000611	CcSEcCtD
Midazolam—Vomiting—Dexamethasone—multiple sclerosis	0.000127	0.000606	CcSEcCtD
Midazolam—Vomiting—Betamethasone—multiple sclerosis	0.000127	0.000606	CcSEcCtD
Midazolam—Rash—Betamethasone—multiple sclerosis	0.000126	0.000601	CcSEcCtD
Midazolam—Rash—Dexamethasone—multiple sclerosis	0.000126	0.000601	CcSEcCtD
Midazolam—Dermatitis—Betamethasone—multiple sclerosis	0.000126	0.000601	CcSEcCtD
Midazolam—Dermatitis—Dexamethasone—multiple sclerosis	0.000126	0.000601	CcSEcCtD
Midazolam—Gastrointestinal disorder—Methotrexate—multiple sclerosis	0.000126	0.000599	CcSEcCtD
Midazolam—Fatigue—Methotrexate—multiple sclerosis	0.000125	0.000599	CcSEcCtD
Midazolam—Headache—Betamethasone—multiple sclerosis	0.000125	0.000598	CcSEcCtD
Midazolam—Headache—Dexamethasone—multiple sclerosis	0.000125	0.000598	CcSEcCtD
Midazolam—Asthenia—Prednisone—multiple sclerosis	0.000125	0.000596	CcSEcCtD
Midazolam—Pain—Methotrexate—multiple sclerosis	0.000124	0.000594	CcSEcCtD
Midazolam—Pruritus—Prednisone—multiple sclerosis	0.000123	0.000588	CcSEcCtD
Midazolam—Feeling abnormal—Methotrexate—multiple sclerosis	0.00012	0.000572	CcSEcCtD
Midazolam—Nausea—Dexamethasone—multiple sclerosis	0.000119	0.000567	CcSEcCtD
Midazolam—Nausea—Betamethasone—multiple sclerosis	0.000119	0.000567	CcSEcCtD
Midazolam—Urticaria—Methotrexate—multiple sclerosis	0.000116	0.000551	CcSEcCtD
Midazolam—Dizziness—Prednisone—multiple sclerosis	0.000115	0.000549	CcSEcCtD
Midazolam—Vomiting—Prednisone—multiple sclerosis	0.000111	0.000528	CcSEcCtD
Midazolam—Rash—Prednisone—multiple sclerosis	0.00011	0.000524	CcSEcCtD
Midazolam—Dermatitis—Prednisone—multiple sclerosis	0.00011	0.000523	CcSEcCtD
Midazolam—Headache—Prednisone—multiple sclerosis	0.000109	0.00052	CcSEcCtD
Midazolam—Hypersensitivity—Methotrexate—multiple sclerosis	0.000107	0.000511	CcSEcCtD
Midazolam—Asthenia—Methotrexate—multiple sclerosis	0.000104	0.000498	CcSEcCtD
Midazolam—Nausea—Prednisone—multiple sclerosis	0.000103	0.000493	CcSEcCtD
Midazolam—Pruritus—Methotrexate—multiple sclerosis	0.000103	0.000491	CcSEcCtD
Midazolam—ABCB1—Allograft Rejection—HLA-DPB1—multiple sclerosis	0.000103	0.00135	CbGpPWpGaD
Midazolam—GABRB3—BDNF signaling pathway—SPP1—multiple sclerosis	0.000101	0.00133	CbGpPWpGaD
Midazolam—CYP4B1—Metabolism—RRM1—multiple sclerosis	0.0001	0.00132	CbGpPWpGaD
Midazolam—GABRR1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	0.0001	0.00132	CbGpPWpGaD
Midazolam—GABRA1—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	9.98e-05	0.00132	CbGpPWpGaD
Midazolam—CYP3A7—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	9.9e-05	0.0013	CbGpPWpGaD
Midazolam—ABCB1—Allograft Rejection—CD40—multiple sclerosis	9.87e-05	0.0013	CbGpPWpGaD
Midazolam—GABRA1—Transmission across Chemical Synapses—BCHE—multiple sclerosis	9.81e-05	0.00129	CbGpPWpGaD
Midazolam—ABCB1—Allograft Rejection—CTLA4—multiple sclerosis	9.72e-05	0.00128	CbGpPWpGaD
Midazolam—Dizziness—Methotrexate—multiple sclerosis	9.62e-05	0.000459	CcSEcCtD
Midazolam—GABRR2—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	9.54e-05	0.00126	CbGpPWpGaD
Midazolam—GABRQ—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	9.54e-05	0.00126	CbGpPWpGaD
Midazolam—GABRB2—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	9.46e-05	0.00125	CbGpPWpGaD
Midazolam—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	9.4e-05	0.00124	CbGpPWpGaD
Midazolam—GABRB2—Neuronal System—BCHE—multiple sclerosis	9.4e-05	0.00124	CbGpPWpGaD
Midazolam—Vomiting—Methotrexate—multiple sclerosis	9.25e-05	0.000441	CcSEcCtD
Midazolam—GABRA5—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	9.19e-05	0.00121	CbGpPWpGaD
Midazolam—Rash—Methotrexate—multiple sclerosis	9.18e-05	0.000438	CcSEcCtD
Midazolam—Dermatitis—Methotrexate—multiple sclerosis	9.17e-05	0.000437	CcSEcCtD
Midazolam—GABRA1—SIDS Susceptibility Pathways—BDNF—multiple sclerosis	9.16e-05	0.00121	CbGpPWpGaD
Midazolam—GABRA5—Neuronal System—BCHE—multiple sclerosis	9.13e-05	0.0012	CbGpPWpGaD
Midazolam—Headache—Methotrexate—multiple sclerosis	9.12e-05	0.000435	CcSEcCtD
Midazolam—CYP2B6—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	9.03e-05	0.00119	CbGpPWpGaD
Midazolam—GABRA3—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	9.03e-05	0.00119	CbGpPWpGaD
Midazolam—GABRA3—Neuronal System—BCHE—multiple sclerosis	8.97e-05	0.00118	CbGpPWpGaD
Midazolam—SLC22A1—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	8.9e-05	0.00117	CbGpPWpGaD
Midazolam—GABRG3—Transmembrane transport of small molecules—AQP4—multiple sclerosis	8.89e-05	0.00117	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—RRM1—multiple sclerosis	8.89e-05	0.00117	CbGpPWpGaD
Midazolam—GABRA2—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	8.87e-05	0.00117	CbGpPWpGaD
Midazolam—CYP2E1—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	8.84e-05	0.00117	CbGpPWpGaD
Midazolam—CYP3A5—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	8.83e-05	0.00116	CbGpPWpGaD
Midazolam—GABRB3—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	8.82e-05	0.00116	CbGpPWpGaD
Midazolam—GABRA2—Neuronal System—BCHE—multiple sclerosis	8.81e-05	0.00116	CbGpPWpGaD
Midazolam—GABRB1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	8.76e-05	0.00115	CbGpPWpGaD
Midazolam—GABRB3—Neuronal System—BCHE—multiple sclerosis	8.75e-05	0.00115	CbGpPWpGaD
Midazolam—GABRA1—SIDS Susceptibility Pathways—IL10—multiple sclerosis	8.75e-05	0.00115	CbGpPWpGaD
Midazolam—GABRG2—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	8.66e-05	0.00114	CbGpPWpGaD
Midazolam—Nausea—Methotrexate—multiple sclerosis	8.64e-05	0.000412	CcSEcCtD
Midazolam—GABRG2—Neuronal System—BCHE—multiple sclerosis	8.6e-05	0.00113	CbGpPWpGaD
Midazolam—ABCB1—Allograft Rejection—HLA-DQA1—multiple sclerosis	8.56e-05	0.00113	CbGpPWpGaD
Midazolam—SLC22A1—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	8.54e-05	0.00113	CbGpPWpGaD
Midazolam—SLC22A1—Transmission across Chemical Synapses—BCHE—multiple sclerosis	8.39e-05	0.00111	CbGpPWpGaD
Midazolam—GABRA6—Transmembrane transport of small molecules—AQP4—multiple sclerosis	8.28e-05	0.00109	CbGpPWpGaD
Midazolam—UGT1A4—Metabolism—CYP27B1—multiple sclerosis	8.28e-05	0.00109	CbGpPWpGaD
Midazolam—UGT1A4—Metabolism—CYP24A1—multiple sclerosis	8.28e-05	0.00109	CbGpPWpGaD
Midazolam—GABRA4—Transmembrane transport of small molecules—AQP4—multiple sclerosis	8.18e-05	0.00108	CbGpPWpGaD
Midazolam—ABCB1—Allograft Rejection—HLA-DQB1—multiple sclerosis	8.01e-05	0.00106	CbGpPWpGaD
Midazolam—GABRG3—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	7.86e-05	0.00104	CbGpPWpGaD
Midazolam—CYP3A4—Biological oxidations—CYP27B1—multiple sclerosis	7.86e-05	0.00104	CbGpPWpGaD
Midazolam—CYP3A4—Biological oxidations—CYP24A1—multiple sclerosis	7.86e-05	0.00104	CbGpPWpGaD
Midazolam—CYP4B1—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	7.78e-05	0.00102	CbGpPWpGaD
Midazolam—CYP3A4—Metapathway biotransformation—CYP27B1—multiple sclerosis	7.75e-05	0.00102	CbGpPWpGaD
Midazolam—CYP3A4—Metapathway biotransformation—CYP24A1—multiple sclerosis	7.75e-05	0.00102	CbGpPWpGaD
Midazolam—GABRB1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	7.74e-05	0.00102	CbGpPWpGaD
Midazolam—ABCB1—Allograft Rejection—CD86—multiple sclerosis	7.71e-05	0.00102	CbGpPWpGaD
Midazolam—UGT1A4—Metabolism—GPC5—multiple sclerosis	7.57e-05	0.000997	CbGpPWpGaD
Midazolam—GABRA1—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	7.57e-05	0.000997	CbGpPWpGaD
Midazolam—ABCB1—Allograft Rejection—IL10—multiple sclerosis	7.56e-05	0.000996	CbGpPWpGaD
Midazolam—ABCB1—Allograft Rejection—CD40LG—multiple sclerosis	7.56e-05	0.000996	CbGpPWpGaD
Midazolam—GABRA1—Neuronal System—BCHE—multiple sclerosis	7.51e-05	0.00099	CbGpPWpGaD
Midazolam—GABRB2—Transmembrane transport of small molecules—AQP4—multiple sclerosis	7.48e-05	0.000986	CbGpPWpGaD
Midazolam—ABCB1—Allograft Rejection—IL4—multiple sclerosis	7.36e-05	0.000969	CbGpPWpGaD
Midazolam—GABRA6—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	7.32e-05	0.000965	CbGpPWpGaD
Midazolam—CYP2B6—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	7.32e-05	0.000965	CbGpPWpGaD
Midazolam—GABRA5—Transmembrane transport of small molecules—AQP4—multiple sclerosis	7.27e-05	0.000958	CbGpPWpGaD
Midazolam—GABRA4—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	7.23e-05	0.000953	CbGpPWpGaD
Midazolam—GABRR1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—multiple sclerosis	7.21e-05	0.00095	CbGpPWpGaD
Midazolam—ABCB1—Allograft Rejection—HLA-B—multiple sclerosis	7.19e-05	0.000948	CbGpPWpGaD
Midazolam—CYP2E1—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	7.17e-05	0.000945	CbGpPWpGaD
Midazolam—UGT1A4—NRF2 pathway—TGFB1—multiple sclerosis	7.16e-05	0.000943	CbGpPWpGaD
Midazolam—CYP3A5—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	7.16e-05	0.000943	CbGpPWpGaD
Midazolam—GABRA3—Transmembrane transport of small molecules—AQP4—multiple sclerosis	7.14e-05	0.00094	CbGpPWpGaD
Midazolam—GABRA2—Transmembrane transport of small molecules—AQP4—multiple sclerosis	7.01e-05	0.000924	CbGpPWpGaD
Midazolam—GABRB3—Transmembrane transport of small molecules—AQP4—multiple sclerosis	6.97e-05	0.000918	CbGpPWpGaD
Midazolam—GABRR2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—multiple sclerosis	6.88e-05	0.000907	CbGpPWpGaD
Midazolam—GABRQ—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—multiple sclerosis	6.88e-05	0.000907	CbGpPWpGaD
Midazolam—GABRG2—Transmembrane transport of small molecules—AQP4—multiple sclerosis	6.84e-05	0.000902	CbGpPWpGaD
Midazolam—ABCB1—Allograft Rejection—FAS—multiple sclerosis	6.78e-05	0.000893	CbGpPWpGaD
Midazolam—ABCB1—Allograft Rejection—IL2RA—multiple sclerosis	6.74e-05	0.000888	CbGpPWpGaD
Midazolam—CYP4B1—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	6.68e-05	0.00088	CbGpPWpGaD
Midazolam—ABCB1—Allograft Rejection—HLA-A—multiple sclerosis	6.66e-05	0.000878	CbGpPWpGaD
Midazolam—GABRB2—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	6.61e-05	0.000871	CbGpPWpGaD
Midazolam—CYP2E1—Vitamin A and Carotenoid Metabolism—MAPK1—multiple sclerosis	6.53e-05	0.00086	CbGpPWpGaD
Midazolam—SLC22A1—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	6.47e-05	0.000853	CbGpPWpGaD
Midazolam—SLC22A1—Neuronal System—BCHE—multiple sclerosis	6.43e-05	0.000847	CbGpPWpGaD
Midazolam—GABRA5—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	6.42e-05	0.000847	CbGpPWpGaD
Midazolam—GABRA3—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	6.31e-05	0.000831	CbGpPWpGaD
Midazolam—UGT1A4—Metabolism—RRM1—multiple sclerosis	6.27e-05	0.000826	CbGpPWpGaD
Midazolam—GABRA2—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	6.2e-05	0.000817	CbGpPWpGaD
Midazolam—GABRB3—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	6.16e-05	0.000812	CbGpPWpGaD
Midazolam—CYP4B1—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	6.09e-05	0.000803	CbGpPWpGaD
Midazolam—ABCB1—Allograft Rejection—HLA-DRB1—multiple sclerosis	6.09e-05	0.000802	CbGpPWpGaD
Midazolam—GABRG2—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	6.05e-05	0.000797	CbGpPWpGaD
Midazolam—GABRA1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	5.98e-05	0.000788	CbGpPWpGaD
Midazolam—CYP4B1—Metabolism—BCHE—multiple sclerosis	5.76e-05	0.000759	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—SRM—multiple sclerosis	5.67e-05	0.000748	CbGpPWpGaD
Midazolam—GABRG3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—multiple sclerosis	5.67e-05	0.000747	CbGpPWpGaD
Midazolam—ABCB1—Allograft Rejection—CD80—multiple sclerosis	5.62e-05	0.000741	CbGpPWpGaD
Midazolam—GABRB1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—multiple sclerosis	5.58e-05	0.000735	CbGpPWpGaD
Midazolam—GABRR1—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	5.42e-05	0.000714	CbGpPWpGaD
Midazolam—GABRA1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	5.29e-05	0.000697	CbGpPWpGaD
Midazolam—GABRA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—multiple sclerosis	5.28e-05	0.000696	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—SRM—multiple sclerosis	5.28e-05	0.000696	CbGpPWpGaD
Midazolam—CYP3A7—Biological oxidations—POMC—multiple sclerosis	5.26e-05	0.000693	CbGpPWpGaD
Midazolam—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—multiple sclerosis	5.21e-05	0.000687	CbGpPWpGaD
Midazolam—GABRR2—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	5.17e-05	0.000682	CbGpPWpGaD
Midazolam—GABRQ—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	5.17e-05	0.000682	CbGpPWpGaD
Midazolam—SLC22A1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	5.12e-05	0.000674	CbGpPWpGaD
Midazolam—ABCB1—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	5.01e-05	0.00066	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—TNFRSF1A—multiple sclerosis	4.87e-05	0.000642	CbGpPWpGaD
Midazolam—GABRB3—BDNF signaling pathway—STAT3—multiple sclerosis	4.78e-05	0.00063	CbGpPWpGaD
Midazolam—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—multiple sclerosis	4.77e-05	0.000628	CbGpPWpGaD
Midazolam—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—multiple sclerosis	4.63e-05	0.00061	CbGpPWpGaD
Midazolam—GABRA1—SIDS Susceptibility Pathways—IL1B—multiple sclerosis	4.59e-05	0.000605	CbGpPWpGaD
Midazolam—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—multiple sclerosis	4.55e-05	0.000599	CbGpPWpGaD
Midazolam—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—multiple sclerosis	4.53e-05	0.000597	CbGpPWpGaD
Midazolam—SLC22A1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	4.52e-05	0.000596	CbGpPWpGaD
Midazolam—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—multiple sclerosis	4.47e-05	0.000589	CbGpPWpGaD
Midazolam—ABCB1—Allograft Rejection—IFNG—multiple sclerosis	4.45e-05	0.000586	CbGpPWpGaD
Midazolam—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—multiple sclerosis	4.44e-05	0.000585	CbGpPWpGaD
Midazolam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—multiple sclerosis	4.36e-05	0.000575	CbGpPWpGaD
Midazolam—GABRB3—BDNF signaling pathway—MAPK1—multiple sclerosis	4.34e-05	0.000572	CbGpPWpGaD
Midazolam—GABRG3—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	4.26e-05	0.000561	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—SRM—multiple sclerosis	4.2e-05	0.000553	CbGpPWpGaD
Midazolam—GABRB1—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	4.2e-05	0.000553	CbGpPWpGaD
Midazolam—GABRR1—Neuronal System—MAPK1—multiple sclerosis	4.15e-05	0.000547	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—SRM—multiple sclerosis	4.11e-05	0.000542	CbGpPWpGaD
Midazolam—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	4.1e-05	0.000541	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—SRM—multiple sclerosis	4.1e-05	0.00054	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—CYP24A1—multiple sclerosis	4e-05	0.000527	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—CYP27B1—multiple sclerosis	4e-05	0.000527	CbGpPWpGaD
Midazolam—GABRA6—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	3.97e-05	0.000523	CbGpPWpGaD
Midazolam—ABCB1—Allograft Rejection—IL1B—multiple sclerosis	3.97e-05	0.000523	CbGpPWpGaD
Midazolam—GABRR2—Neuronal System—MAPK1—multiple sclerosis	3.96e-05	0.000522	CbGpPWpGaD
Midazolam—GABRQ—Neuronal System—MAPK1—multiple sclerosis	3.96e-05	0.000522	CbGpPWpGaD
Midazolam—ABCB1—Allograft Rejection—IL2—multiple sclerosis	3.95e-05	0.000521	CbGpPWpGaD
Midazolam—GABRA4—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	3.92e-05	0.000517	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—multiple sclerosis	3.91e-05	0.000515	CbGpPWpGaD
Midazolam—CYP2B6—Biological oxidations—POMC—multiple sclerosis	3.89e-05	0.000512	CbGpPWpGaD
Midazolam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—multiple sclerosis	3.81e-05	0.000502	CbGpPWpGaD
Midazolam—CYP2E1—Biological oxidations—POMC—multiple sclerosis	3.81e-05	0.000502	CbGpPWpGaD
Midazolam—CYP3A5—Biological oxidations—POMC—multiple sclerosis	3.8e-05	0.000501	CbGpPWpGaD
Midazolam—ABCB1—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	3.8e-05	0.0005	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—CYP27B1—multiple sclerosis	3.72e-05	0.00049	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—CYP24A1—multiple sclerosis	3.72e-05	0.00049	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—GPC5—multiple sclerosis	3.66e-05	0.000482	CbGpPWpGaD
Midazolam—UGT1A4—Metabolism—BCHE—multiple sclerosis	3.6e-05	0.000475	CbGpPWpGaD
Midazolam—GABRR1—Transmembrane transport of small molecules—ALB—multiple sclerosis	3.6e-05	0.000474	CbGpPWpGaD
Midazolam—GABRB2—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	3.59e-05	0.000472	CbGpPWpGaD
Midazolam—GABRA5—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	3.48e-05	0.000459	CbGpPWpGaD
Midazolam—CYP4B1—Metabolism—APOE—multiple sclerosis	3.46e-05	0.000456	CbGpPWpGaD
Midazolam—GABRR2—Transmembrane transport of small molecules—ALB—multiple sclerosis	3.44e-05	0.000453	CbGpPWpGaD
Midazolam—GABRQ—Transmembrane transport of small molecules—ALB—multiple sclerosis	3.44e-05	0.000453	CbGpPWpGaD
Midazolam—GABRA3—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	3.42e-05	0.000451	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—GPC5—multiple sclerosis	3.4e-05	0.000448	CbGpPWpGaD
Midazolam—GABRA2—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	3.36e-05	0.000443	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—multiple sclerosis	3.35e-05	0.000441	CbGpPWpGaD
Midazolam—GABRB3—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	3.34e-05	0.00044	CbGpPWpGaD
Midazolam—GABRA1—SIDS Susceptibility Pathways—TNF—multiple sclerosis	3.33e-05	0.000439	CbGpPWpGaD
Midazolam—CYP3A4—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	3.33e-05	0.000438	CbGpPWpGaD
Midazolam—GABRG2—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	3.28e-05	0.000432	CbGpPWpGaD
Midazolam—GABRG3—Neuronal System—MAPK1—multiple sclerosis	3.26e-05	0.00043	CbGpPWpGaD
Midazolam—GABRB1—Neuronal System—MAPK1—multiple sclerosis	3.21e-05	0.000424	CbGpPWpGaD
Midazolam—SLC22A1—SLC-mediated transmembrane transport—ALB—multiple sclerosis	3.21e-05	0.000422	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—SRM—multiple sclerosis	3.09e-05	0.000408	CbGpPWpGaD
Midazolam—ABCB1—Allograft Rejection—TGFB1—multiple sclerosis	3.08e-05	0.000406	CbGpPWpGaD
Midazolam—GABRA6—Neuronal System—MAPK1—multiple sclerosis	3.04e-05	0.000401	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—RRM1—multiple sclerosis	3.03e-05	0.000399	CbGpPWpGaD
Midazolam—GABRA4—Neuronal System—MAPK1—multiple sclerosis	3e-05	0.000396	CbGpPWpGaD
Midazolam—ABCB1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	3e-05	0.000395	CbGpPWpGaD
Midazolam—CYP4B1—Metabolism—POMC—multiple sclerosis	2.98e-05	0.000392	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—CYP27B1—multiple sclerosis	2.96e-05	0.00039	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—CYP24A1—multiple sclerosis	2.96e-05	0.00039	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—CYP27B1—multiple sclerosis	2.9e-05	0.000382	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—CYP24A1—multiple sclerosis	2.9e-05	0.000382	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—CYP27B1—multiple sclerosis	2.89e-05	0.000381	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—CYP24A1—multiple sclerosis	2.89e-05	0.000381	CbGpPWpGaD
Midazolam—ABCB1—Allograft Rejection—TNF—multiple sclerosis	2.88e-05	0.000379	CbGpPWpGaD
Midazolam—GABRA1—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	2.87e-05	0.000378	CbGpPWpGaD
Midazolam—GABRG3—Transmembrane transport of small molecules—ALB—multiple sclerosis	2.83e-05	0.000373	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—RRM1—multiple sclerosis	2.82e-05	0.000371	CbGpPWpGaD
Midazolam—GABRB1—Transmembrane transport of small molecules—ALB—multiple sclerosis	2.79e-05	0.000367	CbGpPWpGaD
Midazolam—GABRB2—Neuronal System—MAPK1—multiple sclerosis	2.75e-05	0.000362	CbGpPWpGaD
Midazolam—CYP4B1—Metabolism—ALB—multiple sclerosis	2.71e-05	0.000357	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—GPC5—multiple sclerosis	2.7e-05	0.000356	CbGpPWpGaD
Midazolam—GABRA1—SIDS Susceptibility Pathways—IL6—multiple sclerosis	2.69e-05	0.000354	CbGpPWpGaD
Midazolam—GABRA5—Neuronal System—MAPK1—multiple sclerosis	2.67e-05	0.000352	CbGpPWpGaD
Midazolam—ABCB1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	2.65e-05	0.000349	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—GPC5—multiple sclerosis	2.65e-05	0.000349	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—GPC5—multiple sclerosis	2.64e-05	0.000348	CbGpPWpGaD
Midazolam—GABRA6—Transmembrane transport of small molecules—ALB—multiple sclerosis	2.64e-05	0.000347	CbGpPWpGaD
Midazolam—GABRA3—Neuronal System—MAPK1—multiple sclerosis	2.62e-05	0.000345	CbGpPWpGaD
Midazolam—GABRA4—Transmembrane transport of small molecules—ALB—multiple sclerosis	2.6e-05	0.000343	CbGpPWpGaD
Midazolam—GABRA2—Neuronal System—MAPK1—multiple sclerosis	2.58e-05	0.000339	CbGpPWpGaD
Midazolam—GABRB3—Neuronal System—MAPK1—multiple sclerosis	2.56e-05	0.000337	CbGpPWpGaD
Midazolam—GABRG2—Neuronal System—MAPK1—multiple sclerosis	2.51e-05	0.000331	CbGpPWpGaD
Midazolam—SLC22A1—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	2.45e-05	0.000323	CbGpPWpGaD
Midazolam—GABRB2—Transmembrane transport of small molecules—ALB—multiple sclerosis	2.38e-05	0.000314	CbGpPWpGaD
Midazolam—GABRA5—Transmembrane transport of small molecules—ALB—multiple sclerosis	2.31e-05	0.000305	CbGpPWpGaD
Midazolam—GABRA3—Transmembrane transport of small molecules—ALB—multiple sclerosis	2.27e-05	0.000299	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—RRM1—multiple sclerosis	2.24e-05	0.000295	CbGpPWpGaD
Midazolam—GABRA2—Transmembrane transport of small molecules—ALB—multiple sclerosis	2.23e-05	0.000294	CbGpPWpGaD
Midazolam—GABRB3—Transmembrane transport of small molecules—ALB—multiple sclerosis	2.22e-05	0.000292	CbGpPWpGaD
Midazolam—GABRA1—Neuronal System—MAPK1—multiple sclerosis	2.2e-05	0.000289	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—RRM1—multiple sclerosis	2.19e-05	0.000289	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—RRM1—multiple sclerosis	2.19e-05	0.000289	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—CYP24A1—multiple sclerosis	2.18e-05	0.000287	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—CYP27B1—multiple sclerosis	2.18e-05	0.000287	CbGpPWpGaD
Midazolam—GABRG2—Transmembrane transport of small molecules—ALB—multiple sclerosis	2.18e-05	0.000287	CbGpPWpGaD
Midazolam—UGT1A4—Metabolism—APOE—multiple sclerosis	2.17e-05	0.000286	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—GPC5—multiple sclerosis	1.99e-05	0.000263	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—SRM—multiple sclerosis	1.91e-05	0.000251	CbGpPWpGaD
Midazolam—GABRA1—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.9e-05	0.000251	CbGpPWpGaD
Midazolam—SLC22A1—Neuronal System—MAPK1—multiple sclerosis	1.88e-05	0.000248	CbGpPWpGaD
Midazolam—UGT1A4—Metabolism—POMC—multiple sclerosis	1.86e-05	0.000245	CbGpPWpGaD
Midazolam—CYP3A4—Biological oxidations—POMC—multiple sclerosis	1.77e-05	0.000233	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—BCHE—multiple sclerosis	1.74e-05	0.000229	CbGpPWpGaD
Midazolam—UGT1A4—Metabolism—ALB—multiple sclerosis	1.7e-05	0.000224	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—RRM1—multiple sclerosis	1.65e-05	0.000218	CbGpPWpGaD
Midazolam—SLC22A1—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.63e-05	0.000215	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—BCHE—multiple sclerosis	1.62e-05	0.000213	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	1.52e-05	0.000201	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	1.52e-05	0.0002	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	1.49e-05	0.000197	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	1.42e-05	0.000187	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	1.34e-05	0.000177	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	1.34e-05	0.000177	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—BCHE—multiple sclerosis	1.29e-05	0.00017	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—BCHE—multiple sclerosis	1.26e-05	0.000166	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—BCHE—multiple sclerosis	1.26e-05	0.000166	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—GPC5—multiple sclerosis	1.23e-05	0.000162	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—APOE—multiple sclerosis	1.05e-05	0.000138	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—RRM1—multiple sclerosis	1.02e-05	0.000134	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—APOE—multiple sclerosis	9.74e-06	0.000128	CbGpPWpGaD
Midazolam—ABCB1—Transmembrane transport of small molecules—ALB—multiple sclerosis	9.55e-06	0.000126	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—BCHE—multiple sclerosis	9.49e-06	0.000125	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—POMC—multiple sclerosis	8.99e-06	0.000118	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—POMC—multiple sclerosis	8.37e-06	0.00011	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—ALB—multiple sclerosis	8.2e-06	0.000108	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—APOE—multiple sclerosis	7.74e-06	0.000102	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—ALB—multiple sclerosis	7.63e-06	0.000101	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—APOE—multiple sclerosis	7.58e-06	9.99e-05	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—APOE—multiple sclerosis	7.57e-06	9.97e-05	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—POMC—multiple sclerosis	6.65e-06	8.76e-05	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—POMC—multiple sclerosis	6.51e-06	8.58e-05	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—POMC—multiple sclerosis	6.5e-06	8.56e-05	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—ALB—multiple sclerosis	6.06e-06	7.99e-05	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—ALB—multiple sclerosis	5.94e-06	7.82e-05	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—ALB—multiple sclerosis	5.93e-06	7.81e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—BCHE—multiple sclerosis	5.85e-06	7.7e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—APOE—multiple sclerosis	5.71e-06	7.52e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—POMC—multiple sclerosis	4.9e-06	6.46e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—ALB—multiple sclerosis	4.47e-06	5.89e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—APOE—multiple sclerosis	3.52e-06	4.64e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—POMC—multiple sclerosis	3.02e-06	3.98e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—ALB—multiple sclerosis	2.76e-06	3.63e-05	CbGpPWpGaD
